News FluoGuide A/S

Equities

FLUO

DK0061123312

Market Closed - Nasdaq Stockholm Other stock markets 08:50:59 03/05/2024 pm IST			5-day change	1st Jan Change
49.25 ^SEK	-4.55%		+0.72%	-19.53%

20/03	FluoGuide A/S Approves Board Changes	CI
12/03	FluoGuide A/S Enters Collaboration Within Robot Assisted Head and Neck Cancer Surgery with Intuitive Surgical, Inc	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

FluoGuide A/S Approves Board Changes	20/03	CI
Minutes from Annual General Meeting in FluoGuide A/S	20/03	AQ
Chief Financial Officer (CFO) Ole Larsen buys shares	13/03	AQ
FluoGuide enters collaboration within robot assisted head and neck cancer surgery with Intuitive Surgical, a world leading robotic-assisted surgery company	12/03	AQ
FluoGuide A/S Enters Collaboration Within Robot Assisted Head and Neck Cancer Surgery with Intuitive Surgical, Inc	12/03	CI
Notice of Annual General Meeting in FluoGuide A/S	01/03	AQ
Fluoguide Q4 2023 - Bright prospects	28/02	AQ
FluoGuide A/S publishes year-end and annual report for the fiscal year 2023	28/02	AQ
FluoGuide A/S Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
FluoGuide A/S issues warrants to CFO	23/02	AQ
FluoGuide A/S Provides Strategic Update and Outlines Development Plans Towards Commercialization of FG001	08/01	CI
FluoGuide provides strategic update and outlines development plans towards commercialization of FG001	08/01	AQ
FluoGuide raises SEK 12 million through exercise of warrants	11/12	AQ
Chief Development Officer (CDO) Grethe Nørskov Rasmussen sells shares	09/12	AQ
FluoGuide raises SEK 12 million through exercise of warrants	08/12	AQ
Fluoguide Q3 2023 - Spoilt for choice	29/11	AQ
FluoGuide A/S publishes interim report for the period January – September 2023	29/11	AQ
FluoGuide A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11	CI
FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer	13/11	AQ
FluoGuide A/S Announces FG001 Meets Primary Endpoint in Phase LLB Trial in Aggressive Brain Cancer	13/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News FluoGuide A/S

Equities

FLUO

DK0061123312

Summary

Filters